Elekta to Distribute Kobold Medical's Brachytherapy Applicators in US.
M2 PHARMA-June 16, 2016-Elekta to Distribute Kobold Medical's Brachytherapy Applicators in US
(C)2016 M2 COMMUNICATIONS
- Swedish cancer treatment planning systems company Elekta (STO: EKTAB) has recently entered into an agreement to serve as the sole distributor of Kobold Medical's brachytherapy applicators in the United States, the company said.
Adding to its current portfolio of brachytherapy solutions, Elekta will market four Kobold applicators each featuring a 10-year expected life and the Kobold prostate template.
The solutions include The Kobold Fletcher-model Tandem and Ovoid Applicator Set, The Kobold Henschke-model Tandem and Ovoid Applicator Set, The HDR Kobold Tandem and Ring Applicator Set,
The CT-compatible Kobold Vaginal Cylinder Applicator Set and The Kobold Prostate HDR Template.
Elekta develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care.
Currently, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally.
((Comments on this story may be sent to email@example.com))
|Printer friendly Cite/link Email Feedback|
|Date:||Jun 16, 2016|
|Previous Article:||Augmented, Mixed Reality Optical Display Developer Lumus Secures USD 15m Funding.|
|Next Article:||Flex Pharma commences phase two efficacy study in Australian multiple sclerosis patients.|